ARCH Venture Fund VII, L.P. — insider trades

Stock trades ARCH Venture Fund VII, L.P. reported on SEC Form 4 at NMRA Neumora Therapeutics, Inc..

• Oct 27, 2025: bought 1,915,700 shares of NMRA Neumora Therapeutics, Inc. ($5.00M)